世衛(wèi)報告充分肯定中醫(yī)藥抗疫貢獻

Traditional Chinese medicines are beneficial in the treatment of COVID-19, particularly mild to moderate cases, according to a new report released by the World Health Organization.

世界衛(wèi)生組織日前發(fā)布的一份新報告指出，中醫(yī)藥能有效治療新冠肺炎，對輕型和普通型病例尤其有效。

It also encourages member states to consider the potential use of TCM for the management of COVID-19 in the context of their healthcare systems and regulatory frameworks.
世衛(wèi)組織鼓勵會員國在其衛(wèi)生保健系統(tǒng)和監(jiān)管框架內(nèi)考慮使用中醫(yī)藥治療新冠肺炎的可能性。

The report came in late March after a WHO Expert Meeting on Evaluation of TCMs in the Treatment of COVID-19 was held virtually from Feb 28 to March 2.
世衛(wèi)組織中醫(yī)藥救治新冠肺炎專家評估會于2月28日至3月2日以視頻會議形式召開。

The meeting gathered 21 international experts from the six WHO regions to consider three reports, including on clinical service, research and evidence-based evaluation provided by national expert groups in China.
來自世衛(wèi)組織6個地區(qū)辦事處的21名國際專家圍繞臨床實踐、科學研究和循證評價等方面展開研討，對中方專家分享的關(guān)于中醫(yī)藥救治新冠肺炎相關(guān)報告進行了交流和評估，并于3月底形成專家評估會報告。